Architectural firm TRIA announced the completion of Korro Bio’s new headquarters in Cambridge, MA. The office and laboratory fit-out spans 50,000 square feet and marks a significant milestone for the biopharmaceutical company developing RNA-based genetic medicines. It was completed ahead of schedule and under budget.

Korro Bio, which specializes in developing therapies for patients with both rare and highly prevalent diseases, sought a space that would reflect its mission and accommodate its growth. The new headquarters includes open, flexible work environments, dynamic meeting hubs, and lab spaces designed to foster creativity and scientific discovery.

“This project was a fantastic collaboration between Korro Bio’s leadership and our design team,” said Amanda Roderman, project manager at Boston-based TRIA. “Our goal was to design an environment that reflects Korro Bio’s cutting-edge work in the biopharmaceutical field while offering employees a comfortable, dynamic place to thrive.”